{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:40:28Z","timestamp":1780616428708,"version":"3.54.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,16]],"date-time":"2014-05-16T00:00:00Z","timestamp":1400198400000},"content-version":"vor","delay-in-days":349,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.euroneuro.2012.07.003","type":"journal-article","created":{"date-parts":[[2012,7,26]],"date-time":"2012-07-26T17:33:19Z","timestamp":1343323999000},"page":"448-457","source":"Crossref","is-referenced-by-count":36,"title":["Shared and unique genetic contributions to attention deficit\/hyperactivity disorder and substance use disorders: A pilot study of six candidate genes"],"prefix":"10.1016","volume":"23","author":[{"given":"P.J.","family":"Carpentier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Arias Vasquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hoogman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Onnink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.C.","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.J.S.","family":"Kooij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Makkinje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Iskandar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.A.","family":"Kiemeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.A.J.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Franke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.K.","family":"Buitelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2012.07.003_bib1","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.mp.4001504","article-title":"Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden","volume":"9","author":"Bart","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.07.003_bib2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0140-6736(05)66915-2","article-title":"Attention-deficit hyperactivity disorder","volume":"366","author":"Biederman","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2012.07.003_bib3","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/archpsyc.1992.01820090056010","article-title":"Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder. Patterns of comorbidity in probands and relatives psychiatrically and pediatrically referred samples","volume":"49","author":"Biederman","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.07.003_bib4","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1176\/appi.ajp.2007.07091486","article-title":"Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study","volume":"165","author":"Biederman","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.07.003_bib5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1176\/appi.ajp.2007.07030419","article-title":"Familial risk analyses of attention deficit hyperactivity disorder and substance use disorders","volume":"165","author":"Biederman","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.07.003_bib6","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1196\/annals.1417.007","article-title":"Neuronal mechanisms underlying attention deficit hyperactivity disorder: the influence of arousal on prefrontal cortical function","volume":"1129","author":"Brennan","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.euroneuro.2012.07.003_bib7","first-page":"1","article-title":"ADHD: strategies to unravel its genetic architecture","volume":"69","author":"Buitelaar","year":"2005","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.euroneuro.2012.07.003_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/10550887.2011.642756","article-title":"Addiction in developmental perspective: influence of conduct disorder severity, subtype, and attention-deficit hyperactivity disorder on problem severity and comorbidity in adults with opioid dependence","volume":"31","author":"Carpentier","year":"2012","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.euroneuro.2012.07.003_bib9","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3109\/10550490903205652","article-title":"Psychiatric comorbidity reduces quality of life in chronic methadone maintained patients","volume":"18","author":"Carpentier","year":"2009","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.euroneuro.2012.07.003_bib10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000321259","article-title":"Influence of attention deficit hyperactivity disorder and conduct disorder on opioid dependence severity and psychiatric comorbidity in chronic methadone-maintained patients","volume":"17","author":"Carpentier","year":"2011","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.euroneuro.2012.07.003_bib11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/archgenpsychiatry.2007.24","article-title":"A replicated molecular genetic basis for subtyping antisocial behavior in children with attention-deficit\/hyperactivity disorder","volume":"65","author":"Caspi","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.07.003_bib12","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1086\/425589","article-title":"Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain","volume":"75","author":"Chen","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.euroneuro.2012.07.003_bib13","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1176\/appi.ajp.161.4.685","article-title":"Psychopathology risk transmission in children of parents with substance use disorders","volume":"161","author":"Clark","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.07.003_bib14","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/npp.2010.251","article-title":"Child mu-opioid receptor gene variant influences parent\u2013child relations","volume":"36","author":"Copeland","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2012.07.003_bib15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ejpn.2008.06.003","article-title":"The neurobiology of attention deficit\/hyperactivity disorder","volume":"13","author":"Curatolo","year":"2009","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.euroneuro.2012.07.003_bib16","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.pbb.2007.12.021","article-title":"Neurobehavioral mechanisms of impulsivity: fronto-striatal systems and functional neurochemistry","volume":"90","author":"Dalley","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2012.07.003_bib17","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/sj.mp.4000510","article-title":"Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children","volume":"4","author":"Daly","year":"1999","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.07.003_bib18","doi-asserted-by":"crossref","unstructured":"Deyoung, C.G., Getchell, M., Koposov, R.A., Yrigollen, C.M., Haeffel, G.J., Klinteberg, B.A., Oreland, L., Ruchkin, V.V., Pakstis, A.J., Grigorenko, E.L., 2009. Variation in the catechol-O-methyltransferase Val158Met polymorphism associated with conduct disorder and ADHD symptoms, among adolescent male delinquents. Psychiatr. Genet.","DOI":"10.1097\/YPG.0b013e32833511e4"},{"key":"10.1016\/j.euroneuro.2012.07.003_bib19","first-page":"27","article-title":"Dopamine genes and attention-deficit hyperactivity disorder: a review","volume":"28","author":"DiMaio","year":"2003","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.euroneuro.2012.07.003_bib20","doi-asserted-by":"crossref","first-page":"7883","DOI":"10.1073\/pnas.0600871103","article-title":"Mu opioid receptor A118G polymorphism in association with striatal opioid neuropeptide gene expression in heroin abusers","volume":"103","author":"Drakenberg","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.euroneuro.2012.07.003_bib21","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/archpsyc.64.10.1145","article-title":"Prospective effects of attention-deficit\/hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse","volume":"64","author":"Elkins","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.07.003_bib22","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1176\/appi.ajp.157.7.1077","article-title":"Family study of girls with attention deficit hyperactivity disorder","volume":"157","author":"Faraone","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.07.003_bib23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.psc.2009.12.004","article-title":"Molecular genetics of attention deficit hyperactivity disorder","volume":"33","author":"Faraone","year":"2010","journal-title":"Psychiatr. Clin. N. Am."},{"key":"10.1016\/j.euroneuro.2012.07.003_bib24","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.biopsych.2004.11.024","article-title":"Molecular genetics of attention-deficit\/hyperactivity disorder","volume":"57","author":"Faraone","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.07.003_bib25","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1192\/bjp.bp.106.034389","article-title":"Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder","volume":"190","author":"Fayyad","year":"2007","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.07.003_bib26","doi-asserted-by":"crossref","unstructured":"Franke, B., Faraone, S.V., Asherson, P., Buitelaar, J., Bau, C.H., Ramos-Quiroga, J.A., Mick, E., Grevet, E.H., Johansson, S., Haavik, J., Lesch, K.P., Cormand, B., Reif, A., 2011. The genetics of attention deficit\/hyperactivity disorder in adults, a review. Mol. Psychiatry, 10.1038\/mp.2011.138","DOI":"10.1038\/mp.2011.138"},{"key":"10.1016\/j.euroneuro.2012.07.003_bib27","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/ajmg.b.30861","article-title":"Association of the dopamine transporter (SLC6A3\/DAT1) gene 9-6 haplotype with adult ADH","volume":"147B","author":"Franke","year":"2008","journal-title":"Am. J. Med. Genet. B"},{"key":"10.1016\/j.euroneuro.2012.07.003_bib28","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/npp.2009.170","article-title":"Multicenter analysis of the SLC6A3\/DAT1 VNTR haplotype in persistent ADHD suggests differential involvement of the gene in childhood and persistent ADHD","volume":"35","author":"Franke","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2012.07.003_bib29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00439-009-0694-x","article-title":"Candidate gene studies of ADHD: a meta-analytic review","volume":"126","author":"Gizer","year":"2009","journal-title":"Hum. Genet."},{"key":"10.1016\/j.euroneuro.2012.07.003_bib30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.drugalcdep.2007.02.022","article-title":"Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis","volume":"90","author":"Glatt","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.euroneuro.2012.07.003_bib31","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.neubiorev.2008.08.008","article-title":"Poor response inhibition: at the nexus between substance abuse and attention deficit\/hyperactivity disorder","volume":"33","author":"Groman","year":"2009","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.euroneuro.2012.07.003_bib32","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/sj.mp.4001048","article-title":"Serotonergic system and attention deficit hyperactivity disorder (ADHD): a potential susceptibility locus at the 5-HT(1B) receptor gene in 273 nuclear families from a multi-centre sample","volume":"7","author":"Hawi","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.07.003_bib33","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/sj.mp.4001290","article-title":"Linkage disequilibrium mapping at DAT1, DRD5 and DBH narrows the search for ADHD susceptibility alleles at these loci","volume":"8","author":"Hawi","year":"2003","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.07.003_bib34","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1373\/clinchem.2005.055194","article-title":"Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: influences of age and sex","volume":"52","author":"Hoogendoorn","year":"2006","journal-title":"Clin. Chem."},{"key":"10.1016\/j.euroneuro.2012.07.003_bib35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1375\/twin.12.1.53","article-title":"Paternal alcoholism and offspring ADHD problems: a children of twins design","volume":"12","author":"Knopik","year":"2009","journal-title":"Twin Res. Hum. Genet."},{"key":"10.1016\/j.euroneuro.2012.07.003_bib36","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/npp.2009.110","article-title":"Neurocircuitry of addiction","volume":"35","author":"Koob","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2012.07.003_bib37","series-title":"Inleiding in diagnostiek en behandeling","article-title":"ADHD bij volwassenen","author":"Kooij","year":"2002"},{"key":"10.1016\/j.euroneuro.2012.07.003_bib38","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/1087054707299367","article-title":"Reliability, validity, and utility of instruments for self-report and informant report concerning symptoms of ADHD in adult patients","volume":"11","author":"Kooij","year":"2008","journal-title":"J. Atten. Disord."},{"key":"10.1016\/j.euroneuro.2012.07.003_bib39","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1017\/S003329170400337X","article-title":"Internal and external validity of attention-deficit hyperactivity disorder in a population-based sample of adults","volume":"35","author":"Kooij","year":"2005","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2012.07.003_bib40","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1017\/S0033291703001776","article-title":"Efficacy and safety of methylphenidate in 45 adults with attention-deficit\/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial","volume":"34","author":"Kooij","year":"2004","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2012.07.003_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.57.1.1","article-title":"Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments","volume":"57","author":"Kreek","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.euroneuro.2012.07.003_bib42","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/archgenpsychiatry.2010.163","article-title":"Genotype link with extreme antisocial behavior: the contribution of cognitive pathways","volume":"67","author":"Langley","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.07.003_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FBP.0b013e3283242f05","article-title":"Genetics of dopamine receptors and drug addiction: a comprehensive review","volume":"20","author":"Le Foll","year":"2009","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.euroneuro.2012.07.003_bib44","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0376-8716(98)00049-0","article-title":"Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment","volume":"52","author":"Levin","year":"1998","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.euroneuro.2012.07.003_bib45","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1469-7610.2008.01986.x","article-title":"Research review: crossing syndrome boundaries in the search for brain endophenotypes","volume":"50","author":"Levy","year":"2009","journal-title":"J. Child Psychol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.07.003_bib46","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1093\/hmg\/ddl152","article-title":"Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD)","volume":"15","author":"Li","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.euroneuro.2012.07.003_bib47","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1086\/381561","article-title":"Joint analysis of the DRD5 marker concludes association with attention-deficit\/hyperactivity disorder confined to the predominantly inattentive and combined subtypes","volume":"74","author":"Lowe","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.euroneuro.2012.07.003_bib48","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00041444-200212000-00003","article-title":"Dopamine system genes and attention deficit hyperactivity disorder: a meta-analysis","volume":"12","author":"Maher","year":"2002","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.euroneuro.2012.07.003_bib49","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1017\/S0033291708003085","article-title":"Alcohol and illicit drug dependence among parents: associations with offspring externalizing disorders","volume":"39","author":"Marmorstein","year":"2009","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2012.07.003_bib50","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1001\/archpedi.152.10.945","article-title":"Familial risk analysis of the association between attention-deficit\/hyperactivity disorder and psychoactive substance use disorders","volume":"152","author":"Milberger","year":"1998","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"10.1016\/j.euroneuro.2012.07.003_bib51","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0079-6123(08)00926-6","article-title":"Dopamine\u2013serotonin interactions in attention-deficit hyperactivity disorder (ADHD)","volume":"172","author":"Oades","year":"2008","journal-title":"Prog. Brain Res."},{"issue":"2","key":"10.1016\/j.euroneuro.2012.07.003_bib52","doi-asserted-by":"crossref","first-page":"e4410","DOI":"10.1371\/journal.pone.0004410","article-title":"Mu and delta opioid receptors oppositely regulate motor impulsivity in the signaled nose poke task","volume":"4","author":"Olmstead","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.euroneuro.2012.07.003_bib53","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/01.fpc.0000182782.87932.d6","article-title":"Association analysis of polymorphisms in serotonin 1B receptor (HTR1B) gene with heroin addiction: a comparison of molecular and statistically estimated haplotypes","volume":"16","author":"Proudnikov","year":"2006","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.euroneuro.2012.07.003_bib54","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/sj.mp.4002100","article-title":"Exploration of 19 serotoninergic candidate genes in adults and children with attention-deficit\/hyperactivity disorder identifies association for 5HT2A, DDC and MAOB","volume":"14","author":"Ribases","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.07.003_bib55","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/WNF.0b013e3181a9163c","article-title":"The neurobiology of addictive disorders","volume":"32","author":"Ross","year":"2009","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.euroneuro.2012.07.003_bib56","first-page":"55","article-title":"The relationships between attention-deficit\/hyperactive disorder (ADHD), conduct disorder (CD) and problematic drug use (PDU)","volume":"15","author":"Roy","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.euroneuro.2012.07.003_bib57","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4088\/JCP.v61n0402","article-title":"Prevalence of attention-deficit\/hyperactivity disorder and conduct disorder among substance abusers","volume":"61","author":"Schubiner","year":"2000","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.07.003_bib58","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.neubiorev.2003.08.005","article-title":"The dual pathway model of AD\/HD: an elaboration of neuro-developmental characteristics","volume":"27","author":"Sonuga-Barke","year":"2003","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.euroneuro.2012.07.003_bib59","unstructured":"Substance Abuse and Mental Health Services Administration, 2007. Results from the 2006 National Survey on Drug Use and Health: National Findings Office of AppliedStudies, Rockville."},{"key":"10.1016\/j.euroneuro.2012.07.003_bib60","first-page":"28","article-title":"Combined effect of promoter polymorphisms in the dopamine D4 receptor and the serotonin transporter genes in heroin dependence","volume":"7","author":"Szilagyi","year":"2005","journal-title":"Neuropsychopharmacol. Hung."},{"key":"10.1016\/j.euroneuro.2012.07.003_bib61","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.neuropharm.2009.07.026","article-title":"Neurobiology of ADHD","volume":"57","author":"Tripp","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2012.07.003_bib62","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.2217\/14622416.8.10.1427","article-title":"Polymorphisms in the mu-opioid receptor gene (OPRM1) and the implications for alcohol dependence in humans","volume":"8","author":"van der Zwaluw","year":"2007","journal-title":"Pharmacogenomics"},{"issue":"Suppl. 1","key":"10.1016\/j.euroneuro.2012.07.003_bib63","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neuropharm.2008.05.022","article-title":"Imaging dopamine's role in drug abuse and addiction","volume":"56","author":"Volkow","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2012.07.003_bib64","doi-asserted-by":"crossref","first-page":"15079","DOI":"10.1073\/pnas.0812612106","article-title":"Variation in the mu-opioid receptor gene (OPRM1) is associated with dispositional and neural sensitivity to social rejection","volume":"106","author":"Way","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.euroneuro.2012.07.003_bib65","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0193-953X(03)00113-8","article-title":"Attention-deficit\/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues","volume":"27","author":"Wilens","year":"2004","journal-title":"Psychiatr. Clin. N. Am."},{"issue":"Suppl. 11","key":"10.1016\/j.euroneuro.2012.07.003_bib66","first-page":"4","article-title":"The nature of the relationship between attention-deficit\/hyperactivity disorder and substance use","volume":"68","author":"Wilens","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.07.003_bib67","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1542\/peds.111.1.179","article-title":"Does stimulant therapy of attention-deficit\/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature","volume":"111","author":"Wilens","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.euroneuro.2012.07.003_bib68","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/10550490590924872","article-title":"Influence of parental SUD and ADHD on ADHD in their offspring: preliminary results from a pilot-controlled family study","volume":"14","author":"Wilens","year":"2005","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.euroneuro.2012.07.003_bib69","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1098\/rstb.2008.0104","article-title":"Review. Genetics of addictions: strategies for addressing heterogeneity and polygenicity of substance use disorders","volume":"363","author":"Wong","year":"2008","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.euroneuro.2012.07.003_bib70","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1749-6632.2009.05275.x","article-title":"Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment","volume":"1187","author":"Yuferov","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X12001836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X12001836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T19:07:05Z","timestamp":1562008025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X12001836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":70,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0924977X12001836"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2012.07.003","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}